Clinical predictors of azole resistance, outcome and survival from oesophageal candidiasis in AIDS patients

R B Laing, R P Brettle, C L Leen

Research output: Contribution to journalArticlepeer-review

Abstract

A retrospective review of AIDS-related oesophageal candidiasis was undertaken to identify clinical features helpful in predicting response to azole therapy and patient survival. Patients who had received daily azole prophylaxis against candidiasis were significantly less likely to respond to azole therapy than those who had not (P 5% of their body weight in the 2 months before oesophageal candidiasis were less likely to respond to azoles than the others (P
Original languageEnglish
Pages (from-to)16-20
Number of pages5
JournalInternational Journal of STD & AIDS
Volume9
Issue number1
Publication statusPublished - Jan 1998

Keywords

  • AIDS-Related Opportunistic Infections
  • Antifungal Agents
  • Body Weight
  • CD4 Lymphocyte Count
  • Candidiasis
  • Drug Resistance, Microbial
  • Esophageal Diseases
  • Female
  • Fluconazole
  • Humans
  • Ketoconazole
  • Male
  • Retrospective Studies
  • Survivors
  • Treatment Outcome

Fingerprint Dive into the research topics of 'Clinical predictors of azole resistance, outcome and survival from oesophageal candidiasis in AIDS patients'. Together they form a unique fingerprint.

Cite this